New Hypoglycemia Tech Could Have Big Benefits for Diabetes Care The diaTribe Foundation HypoResolve uMotif diatribe.org/new-hypoglycem… via The diaTribe Foundation

Excited to share an overview of the development of the Hypo-RESOLVE QoL at #ISOQOL. ISOQOL HypoResolve SCHARR HEDS SCHARR SCHARR Knowledge Exchange

Montpellier, here we are. 🚀Getting ready for our final #HypoRESOLVE meeting. Looking forward to hearing about the achievements and results of our #hypo #research and, of course, meeting this fantastic team.

It’s Thursday must be another conference #diabetes #hypo-resolve #t2d #t1d #nothingaboutuswithoutus #patientinvolvement #dedoc

Excited to meet and exchange with #HypoRESOLVE partners in Montpellier. A huge ‘Thank you’ to Eric Renard and his team from the Centre Hospitalier Universitaire de Montpellier (CHUM) for hosting our final meeting! Looking forward to updates on the main results from all groups.

👏Great updates this morning on the classification of #hypoglycaemia by Simon Heller and Helen Colhoun, new findings from our @HypoMETRICS study by Pratik Choudhary, @GilMartineEdith, Natalie Zaremba and Patrick Divilly, followed by an update on the #PRO development led by Prof Jill Carlton.

A celebration of our results and friendship, but with a tear in the eye. 🥰

HypoResolve Simon Heller Pratik Choudhary @GilMartineEdith Natalie Zaremba My acknowledgments and sincere thanks to all those involved in the Hypo-RESOLVE QoL development, not least my colleagues Phil Powell 🦋 @philapowell.bsky.social and Donna Rowen. Excited to be able to present preliminary findings on the development of the preference-based version, the Hypo-RESOLVE QoL-8D.

Great to share summary of development of the Hypo-RESOLVE QoL, a patient-reported outcome measure to quantify the impact of hypoglycaemia on HRQoL at the final HypoResolve meeting. A 14-item questionnaire that can be used in research and clinical settings.

Day two HypoResolve where #patientvoice have a chance to speak #nothingsboutuswithoutus #diabetes #t1d #t2d #dedoc #IDFEuropeBXL

Great session with Ken Tait and Mohammed Ahmed representing the Patient Advisory Committee of HypoResolve. Making us all reflect on the need for meaningful partnerships in research. #NothingAboutUsWithoutUs #languagematters #endthestigma 👏

We've had a blast. 🤩It was a such pleasure to meet you and the whole #HypoRESOLVE consortium and learn about the fantastic #results the team delivered. We will now join forces to prepare information materials on the outputs for the #PwD community. 💪

🙏Thanks to this fantastic consortium, the #PwD involved, all our friends who couldn't be with us for this final meeting, our strategic advisors, the fantastic management team, the CHUM team for hosting us... Looking forward to work on communicating our #results. 🥰

HypoResolve Thank you for the opportunity of being here and hearing about the amazing work that was done😀

Keeping an 👁️ on this amazing study!!!

Well this has been an interesting and fantastic week of conferences about two trials involving #diabetes HypoResolve and Trials@Home and including #patientvoice IDFEurope / Diabetes #dedoc Diabetes UK #t2d #t1d #research #trials

Prof Jill Carlton and the HypoResolve team have developed the Hypo-RESOLVE Quality of Life questionnaire (HRQoL), a new method for measuring the impact of #hypoglycaemia that can be used in research and clinical settings.

Daniel Hochfellner and Monika Cigler presenting data from HypoResolve project at our annual meeting receiving good attention from the audience HypoResolve Österreichische Diabetes Gesellschaft Pratik Choudhary Simon Heller Ahmed Iqbal 🇬🇧 Med Uni Graz YD_AUSTRIA Bastiaan De Galan Renza / Diabetogenic Ken Tait Uffe Søholm 🌎

Keep a eye out for more insights from HypoResolve @GilMartineEdith Julia Mader🇺🇦🇺🇦🇦🇹🏳️‍🌈🇪🇺🇮🇱🇺🇦🇺🇦 Diabetes Technology Network UK DTN-UK Advanced Technologies & Treatments for Diabetes

Great work by Gil and colleagues from the HypoResolve study